Behavioral Consequences Among Survivors of Cerebral Malaria and Acceptability to Different Disciplinary Methods
- PMID: 40566354
- PMCID: PMC12192697
- DOI: 10.3390/ijerph22060928
Behavioral Consequences Among Survivors of Cerebral Malaria and Acceptability to Different Disciplinary Methods
Abstract
Cerebral malaria (CM) is a life-threatening disease that affects mainly children in sub-Saharan Africa. Studies have shown that children who survive CM are often left with neurological disabilities after recovery, such as behavioral changes similar to attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). However, diagnosis and treatments for ADHD are limited in many places in Africa. The purpose of this study was to assess behavioral changes following CM infection in Children in Malawi and parents' acceptability of behavioral treatments. Twenty-one parents of children who had survived CM were compared to forty parents from the general population. Assessment instruments included the Disruptive Behavior Rating Scale (DBRS), Treatment Evaluation Inventory-Short Form (TEI-SF), and ADHD symptom checklist. The results showed that the most acceptable treatments among parents in Malawi were interrupt/redirect, discussion, and medication. Parents of CM-surviving children were significantly more accepting of medication (F(1,59) = 7.92, p < 0.007). The majority of the children who survived CM were rated above the clinical cut-off for ADHD and ODD symptoms.
Keywords: ADHD; Malawi; ODD; cerebral malaria; children; treatment acceptability.
Conflict of interest statement
Sam Kabota is affiliated with the Christian Health Association of Malawi (CHAM) non-governmental organization. The authors declare no conflicts of interest.
Similar articles
-
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161373 Free PMC article.
-
Atypical antipsychotics for disruptive behaviour disorders in children and youths.Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008559. doi: 10.1002/14651858.CD008559.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Aug 09;8:CD008559. doi: 10.1002/14651858.CD008559.pub3. PMID: 22972123 Updated.
-
Methylphenidate for children and adolescents with autism spectrum disorder.Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2. Cochrane Database Syst Rev. 2017. PMID: 29159857 Free PMC article.
-
Atypical antipsychotics for disruptive behaviour disorders in children and youths.Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3. Cochrane Database Syst Rev. 2017. PMID: 28791693 Free PMC article.
-
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3. Cochrane Database Syst Rev. 2018. PMID: 29944175 Free PMC article.
References
-
- World Health Organization . World Malaria Report 2023. World Health Organization; Geneva, Switzerland: 2023.
-
- World Health Organization . World Malaria Report 2021, An In-Depth Update on Global and Regional Malaria Data and Trends. World Health Organization; Geneva, Switzerland: 2021.
-
- Centers for Disease Control and Prevention. [(accessed on 3 May 2020)];2017 Available online: https://www.cdc.gov/malaria/about/index.html.
-
- Luo E.K. Malaria. [(accessed on 3 May 2020)]. Available online: https://www.healthline.com/health/malaria.
-
- Parry S. Infections in the Placenta. In: Kay H.H., Nelson M., Wang Y., editors. The Placenta: From Development to Disease. Blackwell Publishing Company; Hoboken, NJ, USA: 2011. pp. 267–268. Chapter 34.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical